Topoisomerase II Beta (TOP2b)

[Edit]

TOPIIB; Top2beta; DNA topoisomerase II, beta isozyme

Topoisomerase II Beta (TOP2b)
DNA topoisomerase 2-beta is a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPD798Hu01 Recombinant Topoisomerase II Beta (TOP2b) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAD798Hu01 Polyclonal Antibody to Topoisomerase II Beta (TOP2b) WB; IHC; ICC; IP.
MAD798Hu21 Monoclonal Antibody to Topoisomerase II Beta (TOP2b) WB; IHC; ICC; IP.
Assay Kits SED798Hu ELISA Kit for Topoisomerase II Beta (TOP2b) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPD798Mu01 Recombinant Topoisomerase II Beta (TOP2b) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAD798Mu01 Polyclonal Antibody to Topoisomerase II Beta (TOP2b) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Topoisomerase II Beta (TOP2b) CLIA Kit Customized Service Offer
n/a ELISA Kit for Topoisomerase II Beta (TOP2b) ELISA Kit Customized Service Offer
  1. "Isolation of cDNA clones encoding the beta isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24."Nucleic Acids Res. 20:5587-5592(1992) [PubMed] [Europe PMC] [Abstract]
  2. "Novel HeLa topoisomerase II is the II beta isoform: complete coding sequence and homology with other type II topoisomerases."Biochim. Biophys. Acta 1172:283-291(1993) [PubMed] [Europe PMC] [Abstract]
  3. "Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes."Proc. Natl. Acad. Sci. U.S.A. 86:9431-9435(1989) [PubMed] [Europe PMC] [Abstract]
  4. "Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplication."Biochim. Biophys. Acta 1444:395-406(1999) [PubMed] [Europe PMC] [Abstract]
  5. "Isolation and characterization of a human cDNA clone encoding a novel DNA topoisomerase II homologue from HeLa cells."FEBS Lett. 266:115-117(1990) [PubMed] [Europe PMC] [Abstract]
  6. "Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma."Biochem. Biophys. Res. Commun. 234:194-197(1997) [PubMed] [Europe PMC] [Abstract]
  7. "Human cells express two differentially spliced forms of topoisomerase II beta mRNA."Nucleic Acids Res. 21:3719-3723(1993) [PubMed] [Europe PMC] [Abstract]
  8. "Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage."Biochemistry 39:1223-1233(2000) [PubMed] [Europe PMC] [Abstract]
  9. "Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta."Biochem. Biophys. Res. Commun. 306:905-911(2003) [PubMed] [Europe PMC] [Abstract]
  10. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
  11. "A probability-based approach for high-throughput protein phosphorylation analysis and site localization."Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract]
  12. "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line."Electrophoresis 28:2027-2034(2007) [PubMed] [Europe PMC] [Abstract]
  13. "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract]
  14. "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis."J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract]
  15. "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment."J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract]
  16. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  17. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
  18. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  19. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  20. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  21. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  22. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  23. "Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide."Science 333:459-462(2011) [PubMed] [Europe PMC] [Abstract]